CDMO – GALENIC DEVELOPMENT
Revealing the full potential of active ingredients that have already proven successful
Revealing the full potential of active ingredients that have already proven successful
Our organisation works on more than 10 different galenic forms, both sterile and non-sterile, as well as more than 40 finished products.
Over the years, this diversity has allowed us to acquire solid know-how that we place at the service of developing formulations (or reformulations) of small molecules. We are convinced that many API still possess an unexploited potential yet to be revealed in order to accelerate therapeutic progress. The desire of our CDMO is to actively contribute to this.
This is why our laboratory also works on the development of new technologies. Our latest unique and worldwide patent is that of MMCR (Multi-layer Microparticle Controlled Release) technology which allows the development of a controlled release syrup (sustained or delayed). A major breakthrough for pediatric populations or people with swallowing impairments.
Sterile forms :
Liquid forms :
Semi-solid forms :
Dry forms :
This web site uses cookies so that we may provide you with the best user experience possible. The information in the cookies is stored in your browser. They are notably used to recognise you when you return to our site and help our team to understand which sections of the web site you find the most interesting and useful.
This web site uses cookies – small text files that are placed on your machine in order to help the site to provide a better user experience. In general, the cookies are used to record the User’s preferences, store information for things such as shopping baskets and supply anonymised tracking data to third party applications such as Google Analytics. As a general rule, the cookies will provide a better browsing experience. However, you may deactivate the cookies in your web browser. We suggest that you consult the Help menu in your browser.